MRVL Marvell Technology, Inc. Insider Trading

President of Data Center Group sells 9,013 shares of MRVL at $199.24 under pre-arranged 10b5-1 plan

Sandeep Bharathi sold 9,013 shares on 2026-07-16 at $199.24 per share as part of a scheduled 10b5-1 trading plan, reducing his non-derivative holdings to 57,139 shares. The timing coincides with a 42.9% decline from the 52-week high ($329.88) and follows an immediate prior sale in June 2026 that showed a 37.0% negative 30-day return. However, his same-ticker history shows mixed outcomes: prior sales in April and March 2026 were followed by positive returns (+35.7% and +65.0% in the 30-day windows, respectively). The sale is mechanical and scheduled rather than discretionary, which limits interpretation of underlying conviction. With 183,362 shares remaining in derivative holdings (RSUs), the insider maintains substantial equity exposure to Marvell despite this non-derivative reduction.

Marvell CEO Matthew Murphy sells 7.5K shares at $209.52 via pre-arranged 10b5-1 plan; stock down -42.9% from 52-week high.

Matthew J Murphy, Chairman and CEO of Marvell Technology, sold 7,500 shares (7.5K shares) at $209.52 on 2026-07-15 for $1,571,400.00 ($1.6M) as part of a pre-arranged 10b5-1 trading plan adopted on 2025-12-16—this is a scheduled, non-discretionary transaction rather than a discretionary sale. Following this trade, Murphy retains 790,686 shares (790.7K shares) of common stock plus derivative holdings of 147,085 restricted stock units across three vehicles, preserving a substantial long-term stake in the company. The stock has declined -42.9% from its 52-week high of $329.88 and is currently trading at $188.30, representing a -32.4% move over the prior 30 days and a +34.8% move over the prior 90 days. Marvell's latest quarter showed revenue of $2,417,800,000.00 ($2.4B) with net income of $34,500,000.00 ($34.5M); annual revenue growth stands at +42.1%, though the elevated P/E of 65.16 reflects substantial market expectations embedded in the current valuation.

MRVL President and COO Chris Koopmans sells 10,000 shares ($2.8M) under pre-arranged 10b5-1 plan; 4-month sell pattern continues despite +154.0% stock run

Chris Koopmans sold 10,000 shares of Marvell at $281.92 on 2026-07-01 as part of a pre-arranged 10b5-1 trading plan adopted on 2026-01-05, reducing his holdings from 237.8K to 227.8K shares. This is the fourth consecutive sell over four months (June, May, April, and now July 2026), following prior sales at MRVL that averaged +32.2%, +26.0%, and +56.2% 30-day returns respectively. The scheduled nature of this trade removes any discretionary timing signal, but the sustained multi-month sell cadence coincides with exceptional stock performance: Marvell has delivered +154.0% 90-day returns and a +24.0% 30-day gain, trading near the top of its 52-week range ($61.44–$329.88). The company's fundamentals show strong revenue growth at +42.1% annually with a $2.4B quarterly revenue base, though the P/E of 94.13 reflects elevated valuation. The pattern of repeated sales during an extended bull run warrants attention to the predetermined execution schedule and its alignment with broader market timing.

CFO Daniel Durn sells 2,250 MRVL shares for $632.3K; cross-ticker sell track record 100% well-timed but stock +42.1% in 30 days

Daniel Durn, CFO of Marvell Technology, sold 2,250 shares for $632,272.50 on 2026-06-23, reducing his holdings by 24.6% to 6,902 shares post-transaction. The sale occurred while the stock has rallied +42.1% over the prior 30 days and +183.4% over 90 days, though it remains -15.4% from its 52-week high of $329.88. Durn's cross-ticker track record shows a 100% well-timed rate on prior sells (3 sales with -11.8% average 90-day return), but his same-ticker history at MRVL is limited to 1 prior buy that returned +5.2% over 90 days. The sale's timing relative to the recent momentum cannot be assessed against his prior performance at this specific security due to the small historical sample.

MRVL President (Data Center Group) sold 2,231 shares at $299.13 via scheduled 10b5-1 plan; retains 55,530 shares plus 28,278 RSUs.

Sandeep Bharathi sold 2,231 shares (-3.9% of pre-transaction holdings) through a pre-arranged 10b5-1 trading plan, a scheduled and automatic execution rather than a discretionary decision. His cross-ticker track record shows 2 prior sells with an average 30-day return of +50.3%, and at MRVL specifically, his two prior sells (on 2026-04-16 and 2026-03-26) each posted strong 30-day returns (+35.7% and +65.0% respectively), though longer-term outcomes remain unmeasured. The stock has appreciated 71.4% over the past 30 days and 223.4% over 90 days from a 52-week low of $61.44, now trading at $289.54, 10.7% below its 52-week high of $324.20. With a P/E of 100.19 and annual revenue growth of +42.1%, the company's valuation reflects elevated multiples on solid fundamentals. Bharathi retains 55,530 non-derivative shares and 28,278 restricted stock units post-transaction, preserving meaningful exposure to the company despite the scheduled sale.

CEO Matthew J Murphy sells 7,500 shares of MRVL at $298.76 (10b5-1 plan); still holds 788,009 shares post-trade.

Matthew J Murphy, Chairman and CEO of Marvell Technology, sold 7,500 shares (7.5K shares) for a total value of $2,240,700.00 ($2.2M) on 2026-06-15 as part of a pre-arranged 10b5-1 trading plan adopted on 2025-12-16. This is a scheduled transaction and not a discretionary trade, meaning no timing inference should be drawn from the sale itself. His post-transaction holdings of 788,009 shares (788.0K shares) remain substantial, representing a minimal -0.9% reduction from his pre-transaction holdings of 795,509 shares (795.5K shares). At MRVL specifically, Murphy's prior three measurable sales have all shown positive 30-day outcomes: +57.8%, +31.6%, and +66.5%, suggesting stock strength continued following prior similar transactions, though the current price of $290.20 is now -10.5% below the 52-week high of $324.20.

Marvell's President and COO Chris Koopmans sold 10,000 shares at $205.87 under pre-arranged 10b5-1 plan; still holds 237,392 shares post-transaction.

Chris Koopmans sold 10,000 shares (10.0K shares) for $2,058,700.00 ($2.1M) on 2026-06-01 under a pre-arranged 10b5-1 trading plan adopted 2026-01-05, reducing his holdings from 247,392 shares (247.4K shares) to 237,392 shares (237.4K shares). Because the transaction is scheduled under a 10b5-1 plan rather than discretionary, it does not reflect a timed market decision. His prior sales at MRVL show varying outcomes: the most recent sale on 2026-05-01 saw the stock rise +26.0% over 90 days, while an earlier sale on 2026-04-06 was followed by +86.0% gains over 90 days, but a 2025-02-18 sale preceded a -41.2% decline over the same period. The company reported net income of $1,901,300,000.00 ($1.9B) on revenue of $2,074,500,000.00 ($2.1B) in the latest quarter, with annual revenue growth of +42.1%, yet trades at a P/E of 31.80 relative to a $191,847,649,000.00 ($191.8B) market cap.

MRVL CFO Meintjes sells 4,000 shares at $175.24 under pre-arranged 10b5-1 plan; retains 226,675 shares post-transaction.

Meintjes Willem A, CFO of Marvell Technology, executed a sale of 4,000 shares at $175.24 on 2026-05-15 under a 10b5-1 trading plan adopted on 2026-01-09, reducing holdings from 230,675 shares to 226,675 shares. The transaction is scheduled and non-discretionary per the trading plan structure. The current stock price of $167.27 is -13.0% from the 52-week high of $192.15, though the stock has risen +19.7% over the prior 30 days and +111.7% over the prior 90 days. The sale occurs within the context of strong recent equity performance and solid fundamentals showing annual revenue growth of +42.1% and a P/E of 24.24.

CEO Murphy sells 7,500 MRVL shares for $1.3M via pre-arranged 10b5-1 plan; stock +37.1% in 30 days

Matthew J Murphy, Chairman and CEO of Marvell Technology, sold 7,500 shares at $177.26 on 2026-05-13 as part of a pre-arranged 10b5-1 trading plan adopted on 2025-12-16, meaning this sale was scheduled and not driven by discretionary conviction. The stock has appreciated significantly since the sale date, rising to $183.52 (current price), with notable 30-day (+37.1%) and 90-day (+133.5%) gains. While Murphy retains substantial holdings of 739,397 shares post-transaction, his historical sell pattern is noteworthy: prior 13 sells averaged a 90-day return of +21.1% after the sales occurred, indicating the stock typically continued climbing after his exits—a pattern suggesting his prior sells were poorly timed. The underlying business fundamentals remain strong with annual revenue growth of +42.1% and net income of $1,901,300,000 against revenue of $2,074,500,000, though the elevated P/E of 26.60 reflects current market optimism.

Marvell COO Koopmans sold 10.0K shares at $162.76; 10b5-1 plan, stock now +37.1% in 30d

Chris Koopmans, President and COO of Marvell Technology, executed a 10,000-share sale on 2026-05-01 at $162.76, part of a pre-arranged 10b5-1 trading plan adopted on 2026-01-05, meaning the transaction was scheduled and not driven by current discretionary conviction. The current stock price of $183.52 reflects a +37.1% 30-day and +133.5% 90-day gain, substantially outpacing the sale price, which signals the market has re-rated MRVL positively since the plan was established. Koopmans' prior sell timing record shows a 50% well-timed rate, and while this particular sale occurred before recent momentum, the underlying fundamentals—revenue of $2,074,500,000 with 42.1% annual growth and net income of $1,901,300,000—support the strong performance. The scheduled nature of this disposition under 10b5-1 precludes interpreting it as an insider capitulation signal, though it may reflect rebalancing or liquidity needs rather than confidence in current valuations.